Knight Therapeutics Inc.

News & Events

Press Releases

In The Media

1. Knight Therapeutics Reports Third Quarter 2025 Results

   GlobeNewswire NOV 6, 2025 7:30 AM EST
   Achieved record-high quarterly revenues, Adjusted EBITDA 1 and Adjusted EBITD...
   Read Article

2. Knight Announces Closing of US$100 Million Revolving Credit Facility

   GlobeNewswire OCT 31, 2025 5:15 PM EDT
   MONTREAL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or ...
   Read Article

3. Knight Therapeutics Announces Launch of JORNAY PM(TM) in Canada

   GlobeNewswire OCT 30, 2025 5:15 PM EDT
   MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan...
   Read Article

4. Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call

   GlobeNewswire OCT 30, 2025 7:30 AM EDT
   MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight&#...
   Read Article

5. Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina

   GlobeNewswire OCT 30, 2025 7:30 AM EDT
   MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan...
   Read Article

6. Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada

   GlobeNewswire OCT 7, 2025 7:30 AM EDT
   MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) (“Knight&...
   Read Article

7. Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada

   GlobeNewswire OCT 7, 2025 7:30 AM EDT
   MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan...
   Read Article

8. Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies

   GlobeNewswire SEP 26, 2025 9:18 AM EDT
   MONTREAL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight&#...
   Read Article

9. Knight Announces Normal Course Issuer Bid

   GlobeNewswire AUG 20, 2025 7:30 AM EDT
   MONTREAL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (" Knight " or...
   Read Article

10. Knight Therapeutics Reports Second Quarter 2025 Results

    GlobeNewswire AUG 7, 2025 7:30 AM EDT
    Achieved record-high quarterly revenues since inception Increased 2025 financial guidan...
    Read Article